Status:
RECRUITING
Registration of Acute Ischemic Stroke With Large and Medium-sized Vascular Occlusion in Southwest China(LMVOS)
Lead Sponsor:
Zhengzhou Yuan
Conditions:
Acute Ischemic Stroke
Eligibility:
All Genders
Brief Summary
This study is designed to observe the treatment options in real-world clinical practice as well as the safety and efficacy of different treatment strategies.
Detailed Description
LMVOS is a prospective, real-world registry lasting for 22 years. A total of 8000 patients with large- or medium-vessel occlusion will be enrolled.
Eligibility Criteria
Inclusion
- The clinical diagnosis is acute ischemic stroke with large- or medium- vessel occlusion (the criteria followed the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018).
- Informed consent from the patient or surrogate.
Exclusion
- No additional exclusion criteria.
Key Trial Info
Start Date :
November 9 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2046
Estimated Enrollment :
8000 Patients enrolled
Trial Details
Trial ID
NCT06125236
Start Date
November 9 2023
End Date
May 1 2046
Last Update
November 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Affiliated Hospital of Southwest Medical University
Luzhou, China, 646000